Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ingrezza medication used for?

See the DrugPatentWatch profile for Ingrezza

What is Ingrezza (valbenazine) used for?

Ingrezza (valbenazine) is used to treat tardive dyskinesia, a movement disorder that causes involuntary facial and body movements, often in people taking antipsychotic medications.

What kind of symptoms does it help with?

It’s prescribed to reduce involuntary movements such as lip smacking, tongue movements, grimacing, and other repetitive facial or body movements associated with tardive dyskinesia.

Who is it typically prescribed for?

Ingrezza is typically used for adults with tardive dyskinesia. Patients are often identified through symptoms that persist despite changes in medication or continued use of antipsychotics.

Is it for other movement disorders too?

Ingrezza’s main approved use is tardive dyskinesia. Other movement disorders may be discussed in clinical research, but the established labeled indication is tardive dyskinesia.

Sources:
(There were no provided sources in the prompt to cite.)



Other Questions About Ingrezza :

ingrezza xr approval date market share ingrezza vs austedo tardive dyskinesia 2023 or 2024 ingrezza annual cost when does ingrezza patent expire ingrezza indications Does ingrezza cause tremors? Market share ingrezza vs austedo for tardive dyskinesia?